317 related articles for article (PubMed ID: 18488412)
21. [Pneumologic emergencies].
Perruchoud A
ZFA (Stuttgart); 1983 Jan; 59(1):24-30. PubMed ID: 6829202
[No Abstract] [Full Text] [Related]
22. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology and management of the complications resulting from fire and the inhaled products of combustion: review of the literature.
Fein A; Leff A; Hopewell PC
Crit Care Med; 1980 Feb; 8(2):94-8. PubMed ID: 7353393
[TBL] [Abstract][Full Text] [Related]
25. Drug nanodelivery systems based on natural polysaccharides against different diseases.
Rehman A; Jafari SM; Tong Q; Riaz T; Assadpour E; Aadil RM; Niazi S; Khan IM; Shehzad Q; Ali A; Khan S
Adv Colloid Interface Sci; 2020 Oct; 284():102251. PubMed ID: 32949812
[TBL] [Abstract][Full Text] [Related]
26. Respiratory disorders of the neonate.
Obladen M; Maier RF
Curr Opin Pediatr; 1993 Apr; 5(2):156-61. PubMed ID: 8374634
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology based targeted drug delivery.
Ruggiero C; Pastorino L; Herrera OL
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3731-2. PubMed ID: 21096863
[TBL] [Abstract][Full Text] [Related]
28. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
[TBL] [Abstract][Full Text] [Related]
29. Potentials of new nanocarriers for dermal and transdermal drug delivery.
Neubert RH
Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle therapeutics: a personal perspective.
McNeil SE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
[TBL] [Abstract][Full Text] [Related]
31. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
Pathak K; Keshri L; Shah M
Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
[TBL] [Abstract][Full Text] [Related]
32. Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations.
Xing Y; Lu P; Xue Z; Liang C; Zhang B; Kebebe D; Liu H; Liu Z
Mini Rev Med Chem; 2020; 20(13):1258-1271. PubMed ID: 32386491
[TBL] [Abstract][Full Text] [Related]
33. Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery.
Wu L; Liu M; Zhu X; Shan W; Huang Y
Curr Pharm Des; 2015; 21(36):5198-211. PubMed ID: 26412355
[TBL] [Abstract][Full Text] [Related]
34. Challenges and potential for RNA nanoparticles (RNPs).
Davis D; Akhtar U; Keaster B; Grozinger K; Washington L; Kelsey S; Sarkar A; DeLong RK
J Biomed Nanotechnol; 2009 Feb; 5(1):36-44. PubMed ID: 20055104
[TBL] [Abstract][Full Text] [Related]
35. The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.
Chenel V; Boissy P; Poirier MS; Cloarec JP; Patenaude J
Int J Nanomedicine; 2015; 10():2125-37; quiz 2138-9. PubMed ID: 25844040
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary complications in neurosurgery.
Ducker TB; Redding JS
Clin Neurosurg; 1976; 23():483-93. PubMed ID: 975698
[No Abstract] [Full Text] [Related]
37. Network medicine, multimorbidity and the lung in the elderly.
Faner R; Cruz T; López-Giraldo A; Agustí A
Eur Respir J; 2014 Sep; 44(3):775-88. PubMed ID: 25063242
[TBL] [Abstract][Full Text] [Related]
38. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
40. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
